{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:53:58Z","timestamp":1794585238646,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008441","name":"Danish Movement Disorder Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008445","name":"Parkinsonforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Accumulating evidence suggests neuroinflammation to be an integrated feature of neurodegeneration. Profiling inflammatory mediators across diseases may reveal common and disease-specific signatures. Here, we focused on progressive supranuclear palsy (PSP), a tauopathy presenting motor and cognitive dysfunction. We screened for 21 cytokines and growth factors in the dorsomedial prefrontal cortex of 16 PSP and 16 control brains using different quantitative techniques. We found and validated increased interleukin (IL)-2 protein levels in the PSP group expressed locally by neurons and glia cells. We further investigated central players in neuroinflammatory pathways and found increased mRNA expression of glycogen synthase kinase 3 beta (<jats:italic>GSK3B<\/jats:italic>). IL-2 and GSK3B proteins are T and natural killer (NK) cell regulators and have previously been associated with other neurodegenerative diseases such as Alzheimer\u2019s disease, Parkinson\u2019s disease and multiple system atrophy. In addition, we identified a shift in peripheral CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cell populations toward increased numbers of memory and reduced numbers of naive T cells. We also observed increased numbers of CD56<jats:sup>+<\/jats:sup> NK cells, but not of CD56<jats:sup>+<\/jats:sup>CD57<jats:sup>+<\/jats:sup> or CD57<jats:sup>+<\/jats:sup> NK cells. Our findings suggest a role for IL-2 in PSP disease processes and point toward active and possibly dysfunctional peripheral immune responses in these patients.<\/jats:p>","DOI":"10.1038\/s41598-019-44234-y","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:03:44Z","timestamp":1558605824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Increased prefrontal cortex interleukin-2 protein levels and shift in the peripheral T cell population in progressive supranuclear palsy patients"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-7533","authenticated-orcid":false,"given":"Rasmus","family":"Rydbirk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betina","family":"Elfving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0940-3098","authenticated-orcid":false,"given":"Jonas","family":"Folke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Pakkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Winge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5453-1817","authenticated-orcid":false,"given":"Tomasz","family":"Brudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"44234_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger, G. U. et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord 32, 853\u2013864, https:\/\/doi.org\/10.1002\/mds.26987 (2017).","journal-title":"Mov Disord"},{"key":"44234_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0022-510X(98)00136-1","volume":"159","author":"F Li","year":"1998","unstructured":"Li, F. et al. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: Comparison with Alzheimer's disease. J Neurol Sci 159, 73\u201381, https:\/\/doi.org\/10.1016\/S0022-510X(98)00136-1 (1998).","journal-title":"J Neurol Sci"},{"key":"44234_CR3","first-page":"427","volume":"54","author":"K Tawana","year":"2001","unstructured":"Tawana, K. & Ramsden, D. Progressive supranuclear palsy. Mol Pathol 54, 427 (2001).","journal-title":"Mol Pathol"},{"key":"44234_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00234-017-1812-4","volume":"59","author":"K Sakurai","year":"2017","unstructured":"Sakurai, K. et al. Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. Neuroradiology 59, 431\u2013443, https:\/\/doi.org\/10.1007\/s00234-017-1812-4 (2017).","journal-title":"Neuroradiology"},{"key":"44234_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/mds.20668","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard, A. et al. In vivo imaging of microglial activation with [11C](R)\u2010PK11195 PET in progressive supranuclear palsy. Mov Disord 21, 89\u201393, https:\/\/doi.org\/10.1002\/mds.20668 (2006).","journal-title":"Mov Disord"},{"key":"44234_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/ijms17020206","volume":"17","author":"I L\u00f3pez Gonz\u00e1lez","year":"2016","unstructured":"L\u00f3pez Gonz\u00e1lez, I., Garcia-Esparcia, P., Llorens, F. & Ferrer, I. Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies. Int J Mol Sci 17, 206, https:\/\/doi.org\/10.3390\/ijms17020206 (2016).","journal-title":"Int J Mol Sci"},{"key":"44234_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.parkreldis.2011.06.007","volume":"17","author":"R Fernandez-Botran","year":"2011","unstructured":"Fernandez-Botran, R. et al. Cytokine expression and microglial activation in progressive supranuclear palsy. Parkinsonism Relat Disord 17, 683\u2013688, https:\/\/doi.org\/10.1016\/j.parkreldis.2011.06.007 (2011).","journal-title":"Parkinsonism Relat Disord"},{"key":"44234_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 12, 180, https:\/\/doi.org\/10.1038\/nri3156 (2012).","journal-title":"Nat Rev Immunol"},{"key":"44234_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.nbd.2017.07.014","volume":"106","author":"R Rydbirk","year":"2017","unstructured":"Rydbirk, R. et al. Cytokine profiling in the prefrontal cortex of Parkinson\u2019s Disease and Multiple System Atrophy patients. Neurobiol Dis 106, 269\u2013278, https:\/\/doi.org\/10.1016\/j.nbd.2017.07.014 (2017).","journal-title":"Neurobiol Dis"},{"key":"44234_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1567-7443(07)10008-9","volume":"6","author":"M Prinz","year":"2008","unstructured":"Prinz, M., Van Rossum, D. & Hanisch, U.-K. Interleukin-2 as a neuroregulatory cytokine. NeuroImmune Biol 6, 145\u2013165, https:\/\/doi.org\/10.1016\/S1567-7443(07)10008-9 (2008).","journal-title":"NeuroImmune Biol"},{"key":"44234_CR11","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","volume":"354","author":"A Schrag","year":"1999","unstructured":"Schrag, A., Ben-Shlomo, Y. & Quinn, N. P. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354, 1771\u20131775, https:\/\/doi.org\/10.1016\/S0140-6736(99)04137-9 (1999).","journal-title":"Lancet"},{"key":"44234_CR12","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.4049\/jimmunol.181.12.8363","volume":"181","author":"CA Garcia","year":"2008","unstructured":"Garcia, C. A. et al. Antigenic Experience Dictates Functional Role of Glycogen Synthase Kinase-3 in Human CD4+ T Cell Responses. J Immunol 181, 8363\u20138371, https:\/\/doi.org\/10.4049\/jimmunol.181.12.8363 (2008).","journal-title":"J Immunol"},{"key":"44234_CR13","doi-asserted-by":"publisher","first-page":"e0186764","DOI":"10.1371\/journal.pone.0186764","volume":"12","author":"Q Cao","year":"2017","unstructured":"Cao, Q., Karthikeyan, A., Dheen, S. T., Kaur, C. & Ling, E.-A. Production of proinflammatory mediators in activated microglia is synergistically regulated by Notch-1, glycogen synthase kinase (GSK-3\u03b2) and NF-\u03baB\/p65 signalling. Plos One 12, e0186764, https:\/\/doi.org\/10.1371\/journal.pone.0186764 (2017).","journal-title":"Plos One"},{"key":"44234_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.expneurol.2009.09.011","volume":"223","author":"F Hern\u00e1ndez","year":"2010","unstructured":"Hern\u00e1ndez, F., de Barreda, E. G., Fuster-Matanzo, A., Lucas, J. J. & Avila, J. GSK3: a possible link between beta amyloid peptide and tau protein. Exp Neurol 223, 322\u2013325, https:\/\/doi.org\/10.1016\/j.expneurol.2009.09.011 (2010).","journal-title":"Exp Neurol"},{"key":"44234_CR15","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.parkreldis.2015.09.033","volume":"22","author":"C Koros","year":"2016","unstructured":"Koros, C. & Stamelou, M. Interventions in progressive supranuclear palsy. Parkinsonism Relat Disord 22, S93\u2013S95, https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.033 (2016).","journal-title":"Parkinsonism Relat Disord"},{"key":"44234_CR16","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1073\/pnas.92.16.7545","volume":"92","author":"V Renard","year":"1995","unstructured":"Renard, V. et al. Normal development and function of natural killer cells in CD3 epsilon delta 5\/delta 5 mutant mice. PNAS 92, 7545\u20137549, https:\/\/doi.org\/10.1073\/pnas.92.16.7545 (1995).","journal-title":"PNAS"},{"key":"44234_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","volume":"38","author":"W Liao","year":"2013","unstructured":"Liao, W., Lin, J.-X. & Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13\u201325, https:\/\/doi.org\/10.1016\/j.immuni.2013.01.004 (2013).","journal-title":"Immunity"},{"key":"44234_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1749-6632.2009.05126.x","volume":"1183","author":"JJ Obar","year":"2010","unstructured":"Obar, J. J. & Lefran\u00e7ois, L. Memory CD8+ T cell differentiation. Ann. N. Y. Acad. Sci. 1183, 251\u2013266, https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05126.x (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"44234_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/mds.25761","volume":"29","author":"JA Santiago","year":"2014","unstructured":"Santiago, J. A. & Potashkin, J. A. A network approach to diagnostic biomarkers in progressive supranuclear palsy. Mov Disord 29, 550\u2013555, https:\/\/doi.org\/10.1002\/mds.25761 (2014).","journal-title":"Mov Disord"},{"key":"44234_CR20","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/brain\/aww330","volume":"140","author":"S Alves","year":"2017","unstructured":"Alves, S. et al. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice. Brain 140, 826\u2013842, https:\/\/doi.org\/10.1093\/brain\/aww330 (2017).","journal-title":"Brain"},{"key":"44234_CR21","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","volume":"139","author":"C Dansokho","year":"2016","unstructured":"Dansokho, C. et al. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain 139, 1237\u20131251, https:\/\/doi.org\/10.1093\/brain\/awv408 (2016).","journal-title":"Brain"},{"key":"44234_CR22","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1093\/brain\/awx108","volume":"140","author":"C Dansokho","year":"2017","unstructured":"Dansokho, C., Aucouturier, P. & Dorothee, G. Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology. Brain 140, e39, https:\/\/doi.org\/10.1093\/brain\/awx108 (2017).","journal-title":"Brain"},{"key":"44234_CR23","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1093\/brain\/awx109","volume":"140","author":"S Alves","year":"2017","unstructured":"Alves, S., Churlaud, G., Klatzmann, D. & Cartier, N. Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology. Brain 140, e40\u2013e40, https:\/\/doi.org\/10.1093\/brain\/awx109 (2017).","journal-title":"Brain"},{"key":"44234_CR24","doi-asserted-by":"crossref","unstructured":"Lantos, P. The neuropathology of progressive supranuclear palsy. J Neural Transm-Supp, 137\u2013152 (1994).","DOI":"10.1007\/978-3-7091-6641-3_11"},{"key":"44234_CR25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association Declaration of Helsinki","year":"2013","unstructured":"World Medical Association Declaration of Helsinki. ethical principles for medical research involving human subjects. Jama 310, 2191\u20132194, https:\/\/doi.org\/10.1001\/jama.2013.281053 (2013).","journal-title":"Jama"},{"key":"44234_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248\u2013254 (1976).","journal-title":"Anal Biochem"},{"key":"44234_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55, 611\u2013622, https:\/\/doi.org\/10.1373\/clinchem.2008.112797 (2009).","journal-title":"Clin Chem"},{"key":"44234_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jneumeth.2007.06.001","volume":"165","author":"S Weis","year":"2007","unstructured":"Weis, S. et al. Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Methods 165, 198\u2013209, https:\/\/doi.org\/10.1016\/j.jneumeth.2007.06.001 (2007).","journal-title":"J Neurosci Methods"},{"key":"44234_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep37116","volume":"6","author":"R Rydbirk","year":"2016","unstructured":"Rydbirk, R. et al. Assessment of brain reference genes for RT-qPCR studies in neurodegenerative diseases. Sci Rep 6, 37116, https:\/\/doi.org\/10.1038\/srep37116 (2016).","journal-title":"Sci Rep"},{"key":"44234_CR30","doi-asserted-by":"publisher","first-page":"12178","DOI":"10.1074\/jbc.M900994200","volume":"284","author":"W Yan","year":"2009","unstructured":"Yan, W. & Chen, X. Identification of GRO1 as a critical determinant for mutant p53 gain of function. The Journal of biological chemistry 284, 12178\u201312187, https:\/\/doi.org\/10.1074\/jbc.M900994200 (2009).","journal-title":"The Journal of biological chemistry"},{"key":"44234_CR31","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT\u2013PCR. Nucleic Acids Res 29, e45, https:\/\/doi.org\/10.1093\/nar\/29.9.e45 (2001).","journal-title":"Nucleic Acids Res"},{"key":"44234_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jmoldx.2011.05.008","volume":"13","author":"LJ Massingham","year":"2011","unstructured":"Massingham, L. J. et al. Proof of concept study to assess fetal gene expression in amniotic fluid by nanoarray PCR. J Mol Diagn 13, 565\u2013570, https:\/\/doi.org\/10.1016\/j.jmoldx.2011.05.008 (2011).","journal-title":"J Mol Diagn"},{"key":"44234_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12033-012-9539-2","volume":"52","author":"D Lanoix","year":"2012","unstructured":"Lanoix, D. et al. Quantitative PCR pitfalls: the case of the human placenta. Mol Biotechnol 52, 234\u2013243, https:\/\/doi.org\/10.1007\/s12033-012-9539-2 (2012).","journal-title":"Mol Biotechnol"},{"key":"44234_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-2-r19","volume":"8","author":"J Hellemans","year":"2007","unstructured":"Hellemans, J., Mortier, G., De Paepe, A., Speleman, F. & Vandesompele, J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8, R19, https:\/\/doi.org\/10.1186\/gb-2007-8-2-r19 (2007).","journal-title":"Genome Biol"},{"key":"44234_CR35","doi-asserted-by":"crossref","unstructured":"R: A Language and Environment for Statistical Computing v. 3.4.1 (R Foundation for Statistical Computing, 2017).","DOI":"10.1201\/9780203758212-1"},{"key":"44234_CR36","unstructured":"Fox, J. & Weisberg, S. An R Companion to Applied Regression. Second Edition edn, (SAGE Publications, Inc., 2011)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44234-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44234-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44234-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:56:43Z","timestamp":1671271003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44234-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44234"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44234-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]},"assertion":[{"value":"15 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7781"}}